Innate Pharma
Price & Volume
Stats
See more52W Range | $1.17-$2.62 |
Market Cap | $167.6M |
Shares Short | 163,552 |
Financials
See moreRevenue (12 Mos) | $9M |
Revenue Growth (YoY) | -46.7% |
Gross Profit (12 Mos) | -$34.6M |
Diluted EPS | -$0.65 |
News
See moreYahoo Finance • 3 months ago
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
Yahoo Finance • 3 months ago
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
Yahoo Finance • 4 months ago
Innate Pharma SA (IPHA) Full Year 2025 Earnings Call Highlights: Strategic Advances and ...
Yahoo Finance • 4 months ago
Innate Pharma Reports Full Year 2025 Financial Results and Business Update
About
CEO | Mr. Jonathan E. Dickinson B.Sc., M.B.A. |
CFO | Mr. Frederic Lombard M.B.A. |
Address | 117, Avenue de Luminy, Marseille, France, 13009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 164 |